Study of Fatty Acid Binding Protein 4 (FABP4) levels in Patients with Beta-thalassemia and its Related Complications... | ||
| Fayoum University Medical Journal | ||
| Volume 13, Issue 2, April 2024, Pages 42-48 PDF (291.16 K) | ||
| Document Type: Full Length research Papers | ||
| DOI: 10.21608/fumj.2024.258395.1301 | ||
| Author | ||
| Basma Atiya Mohamed* | ||
| Internal Medicine, Faculty of Medicine, Fayoum University | ||
| Abstract | ||
| Abstract Introduction: Due to iron overload, patients with beta-thalassemia may experience complications. Several adipokines have been proposed as potential contributors to the development of β-thalassemia complications. One of the adipokines, fatty acid-binding protein 4 (FABP4), connects various elements of the inflammatory and metabolic pathways. Aim of the study: This study assessed β-thalassemia patients' serum (FABP4) levels and linked them to complications related to thalassemia. Subjects and Methods: There were fifty adult participants in this cross-sectional study. A thorough clinical examination and medical history were completed. Every participant had their serum levels of fatty acid binding protein four measured. Results: According to our findings, 24% of patients had HCV+ve, 36% had gall bladder stones, and 44% had elevated liver enzymes. Patients with serum ferritin levels greater than 2500 ng/ml and FABP4 levels did not significantly correlate (p < 0.05). Conclusions: Patients with β-thalassemia had elevated liver enzymes, GB stones, and a high prevalence of HCV+. There was no discernible relationship between patients with serum ferritin levels higher than 2500 ng/mL and FABP4 levels. | ||
| Keywords | ||
| FABP4; β-thalassemia; complications | ||
|
Statistics Article View: 83 PDF Download: 195 |
||
